TNSN06009A1 - Derives de pyrrolo [3,4-c] pyrazole actifs comme inhibiteurs de kinases - Google Patents

Derives de pyrrolo [3,4-c] pyrazole actifs comme inhibiteurs de kinases

Info

Publication number
TNSN06009A1
TNSN06009A1 TNP2006000009A TNSN06009A TNSN06009A1 TN SN06009 A1 TNSN06009 A1 TN SN06009A1 TN P2006000009 A TNP2006000009 A TN P2006000009A TN SN06009 A TNSN06009 A TN SN06009A TN SN06009 A1 TNSN06009 A1 TN SN06009A1
Authority
TN
Tunisia
Prior art keywords
dans
kinase inhibitors
pyrrolo
pyrazole derivatives
des
Prior art date
Application number
TNP2006000009A
Other languages
English (en)
Inventor
Mario Varasi
Paola Vianello
Daniele Fancelli
Barbara Forte
Jurgen Moll
Original Assignee
Pfizer Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Italia Srl filed Critical Pfizer Italia Srl
Publication of TNSN06009A1 publication Critical patent/TNSN06009A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

DES DERIVES DE PYRROLO [3,4-C] PYRAZOLE DE FORMULE (1) ET LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES, TELS QUE DEFINIS DANS LE PRESENT MEMOIRE, UN PROCEDE POUR LEUR PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT SONT DECRITS ; LES COMPOSES DE LA PRESENTE INVENTION PEUVENT ETRE UTILES, EN THERAPEUTIQUE, DANS LE TRAITEMENT DE MALADIES ASSOCIEES A UNE DEREGULATION D'ACTIVITE DE PROTEINE-KINASES, TELLES QUE LE CANCER.
TNP2006000009A 2003-07-09 2006-01-09 Derives de pyrrolo [3,4-c] pyrazole actifs comme inhibiteurs de kinases TNSN06009A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48581403P 2003-07-09 2003-07-09
PCT/EP2004/007515 WO2005005427A1 (fr) 2003-07-09 2004-07-08 Derives du pyrrolo[3,4-c]pyrazole actifs comme inhibiteurs des kinases

Publications (1)

Publication Number Publication Date
TNSN06009A1 true TNSN06009A1 (fr) 2007-10-03

Family

ID=34062099

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000009A TNSN06009A1 (fr) 2003-07-09 2006-01-09 Derives de pyrrolo [3,4-c] pyrazole actifs comme inhibiteurs de kinases

Country Status (42)

Country Link
US (2) US7141568B2 (fr)
EP (1) EP1644376B1 (fr)
JP (1) JP4728232B2 (fr)
KR (1) KR101075711B1 (fr)
CN (1) CN100564380C (fr)
AP (1) AP2214A (fr)
AR (1) AR050045A1 (fr)
AT (1) ATE480540T1 (fr)
AU (1) AU2004255347B2 (fr)
BR (1) BRPI0411868B8 (fr)
CA (1) CA2531759C (fr)
CR (1) CR8171A (fr)
CY (1) CY1110832T1 (fr)
DE (1) DE602004029045D1 (fr)
DK (1) DK1644376T3 (fr)
DO (1) DOP2004000949A (fr)
EA (1) EA009462B1 (fr)
EC (1) ECSP056246A (fr)
ES (1) ES2349780T3 (fr)
GE (1) GEP20084395B (fr)
GT (2) GT200400133A (fr)
HK (1) HK1089769A1 (fr)
HN (1) HN2004000232A (fr)
IL (1) IL172923A (fr)
IS (1) IS2843B (fr)
MA (1) MA28064A1 (fr)
ME (1) MEP51908A (fr)
MX (1) MXPA06000362A (fr)
MY (1) MY139072A (fr)
NO (1) NO332361B1 (fr)
NZ (1) NZ544514A (fr)
PA (1) PA8606201A1 (fr)
PE (1) PE20050325A1 (fr)
PL (1) PL1644376T3 (fr)
PT (1) PT1644376E (fr)
RS (2) RS20060004A (fr)
SI (1) SI1644376T1 (fr)
TN (1) TNSN06009A1 (fr)
TW (1) TWI343382B (fr)
UA (1) UA81682C2 (fr)
WO (1) WO2005005427A1 (fr)
ZA (1) ZA200600095B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006381B1 (ru) * 2000-08-10 2005-12-29 Фармация Италия С.П.А. Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
CA2539549A1 (fr) * 2003-09-23 2005-04-07 Vertex Pharmaceuticals Incorporated Derives de pyrazolopyrrole utilises en tant qu'inhibiteurs de proteines kinases
EP1694686A1 (fr) * 2003-12-19 2006-08-30 Takeda San Diego, Inc. Inhibiteurs de kinase
JP2007533753A (ja) * 2004-04-23 2007-11-22 タケダ サン ディエゴ インコーポレイテッド インドール誘導体及びキナーゼ阻害剤としてのその使用
EP1778669A2 (fr) * 2004-08-18 2007-05-02 Takeda San Diego, Inc. Inhibiteurs de kinase
WO2006044687A2 (fr) 2004-10-15 2006-04-27 Takeda San Diego, Inc. Inhibiteurs de kinase
CA2593428C (fr) * 2005-01-10 2012-04-17 Pfizer Inc. Pyrrolopyrazoles, puissants inhibiteurs de kinases
US8119655B2 (en) * 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
TW200808311A (en) 2006-03-30 2008-02-16 Nerviano Medical Sciences Srl Use of a kinase inhibitor for the treatment of particular resistant tumors
WO2008017465A1 (fr) * 2006-08-10 2008-02-14 F. Hoffmann-La Roche Ag Dérivés de lactame bicycliques, leur fabrication et utilisation en tant qu'agents pharmaceutiques
BRPI0719883A2 (pt) 2006-10-09 2015-05-05 Takeda Pharmaceutical Inibidores de quinase
JP2010505961A (ja) * 2006-10-09 2010-02-25 タケダ サン ディエゴ インコーポレイテッド キナーゼ阻害剤
ATE479432T1 (de) * 2006-11-03 2010-09-15 Nerviano Medical Sciences Srl Verfahren zur verabreichung einer antitumoralen verbindung
AR071780A1 (es) 2008-05-15 2010-07-14 Nerviano Medical Sciences Srl Derivados de carbamoilo de carbonilamino-pirazoles biciclicos como profarmacos
CN102105148B (zh) * 2008-07-24 2013-04-10 内尔维阿诺医学科学有限公司 包含aurora激酶抑制剂和抗肿瘤药的治疗组合
US20110117212A1 (en) * 2008-07-24 2011-05-19 Nerviano Medical Sciences S.R.L. Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent
US20100022553A1 (en) * 2008-07-24 2010-01-28 Nerviano Medical Sciences S.R.L. Therapeutic Combination Comprising an Aurora Kinase Inhibitor and Imatinib
JP5738196B2 (ja) 2008-12-22 2015-06-17 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． オーロラキナーゼ阻害剤および抗ｃｄ２０抗体の併用
WO2013088257A1 (fr) 2011-12-12 2013-06-20 Dr. Reddy's Laboratories Ltd. Composés hétérocycliques substitués en tant qu'inhibiteurs du récepteur kinase a lié à la tropomyosine (trka)
CN104072498B (zh) * 2013-03-26 2016-12-28 沈阳药科大学 （R）‑N‑[5‑(2‑甲氧基‑2‑苯基乙酰基)‑1,4,5,6‑四氢吡咯并[3,4‑c]吡唑‑3‑基]‑4‑(4‑甲基哌嗪‑1‑基)苯甲酰胺的合成方法
US10335494B2 (en) 2013-12-06 2019-07-02 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-CD30 antibodies
CA2953177C (fr) 2014-06-23 2019-07-23 Dr. Reddy's Laboratories Ltd. Composes d'imidazo[1,2-a]pyridine substitue utiles pour le traitement de la douleur
RU2765718C1 (ru) * 2015-06-15 2022-02-02 Убе Индастриз, Лтд. Замещенное производное дигидропирролопиразола
CN107337674B (zh) * 2016-04-29 2019-09-20 江苏吉贝尔药业股份有限公司 用于dpp-iv抑制剂的四氢吡喃胺衍生物、其药物组合物和制剂以及用途
US11874276B2 (en) 2018-04-05 2024-01-16 Dana-Farber Cancer Institute, Inc. STING levels as a biomarker for cancer immunotherapy
WO2021041532A1 (fr) 2019-08-26 2021-03-04 Dana-Farber Cancer Institute, Inc. Utilisation d'héparine pour favoriser la signalisation de l'interféron de type 1
CN113563346A (zh) * 2021-08-19 2021-10-29 守恒(厦门)医疗科技有限公司 吡咯[3,4-c]并吡唑二酰胺类衍生物及其在抗肿瘤药物中的应用
WO2023196959A1 (fr) 2022-04-07 2023-10-12 Eli Lilly And Company Procédé de fabrication d'un inhibiteur de kras g12c
WO2023196887A1 (fr) 2022-04-08 2023-10-12 Eli Lilly And Company Méthode de traitement comprenant des inhibiteurs de kras g12c et des inhibiteurs d'aurora a
US20240108618A1 (en) 2022-06-30 2024-04-04 Eli Lilly And Company Kras g12c inhibitor dosing regimens

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717380B1 (fr) * 1994-03-15 1996-04-26 Oreal Compositions cosmétiques contenant un mélange synergétique de polymères conditionneurs.
GB9911053D0 (en) 1999-05-12 1999-07-14 Pharmacia & Upjohn Spa 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
DE19932144A1 (de) * 1999-07-09 2001-01-11 Basf Ag Mikrokapselzubereitungen und Mikrokapseln enthaltende Wasch- und Reinigungsmittel
YU9602A (sh) 1999-08-12 2004-11-25 Pharmacia Italia S.P.A. Derivati 3(5)-amino-pirazola, postupak za njihovu izradu i njihova upotreba kao antitumornih agenasa
US6387900B1 (en) 1999-08-12 2002-05-14 Pharmacia & Upjohn S.P.A. 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
EA006381B1 (ru) 2000-08-10 2005-12-29 Фармация Италия С.П.А. Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
FR2815032B1 (fr) 2000-10-10 2003-08-08 Pf Medicament Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
NZ525892A (en) 2000-11-27 2004-11-26 Pharmacia Italia S Phenylacetamido- pyrazole derivatives their use as antitumor agents and preparation process thereof
MXPA03006478A (es) 2001-01-26 2003-09-22 Pharmacia Italia Spa Derivados de cromano, procedimiento para su preparacion y su uso como agentes antitumorales.
EP1820503B1 (fr) 2001-09-26 2012-02-22 Pfizer Italia S.r.l. Dérivés d'aminoindazole actifs en tant qu'inhibiteurs de la kinase, leur procédé de préparation et compositions pharmaceutiques les contenant
US20060100233A1 (en) 2002-07-25 2006-05-11 Manuela Villa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
GT200400133AA (es) 2007-07-10
RS52155B (en) 2012-08-31
RS20060004A (en) 2008-06-05
AR050045A1 (es) 2006-09-27
EP1644376A1 (fr) 2006-04-12
JP4728232B2 (ja) 2011-07-20
ATE480540T1 (de) 2010-09-15
TWI343382B (en) 2011-06-11
BRPI0411868B8 (pt) 2021-05-25
PE20050325A1 (es) 2005-05-17
NO332361B1 (no) 2012-09-03
PA8606201A1 (es) 2005-08-04
MXPA06000362A (es) 2006-03-28
IL172923A (en) 2011-09-27
CY1110832T1 (el) 2015-06-10
US20060276471A1 (en) 2006-12-07
KR20060033001A (ko) 2006-04-18
AU2004255347A1 (en) 2005-01-20
KR101075711B1 (ko) 2011-10-21
MEP51908A (en) 2011-05-10
EP1644376B1 (fr) 2010-09-08
CA2531759C (fr) 2013-04-02
NZ544514A (en) 2009-07-31
DE602004029045D1 (de) 2010-10-21
US7582628B2 (en) 2009-09-01
DK1644376T3 (da) 2011-01-03
CN100564380C (zh) 2009-12-02
IS8192A (is) 2005-12-22
IL172923A0 (en) 2006-06-11
US7141568B2 (en) 2006-11-28
NO20060113L (no) 2006-04-05
AP2006003480A0 (en) 2006-02-28
ZA200600095B (en) 2007-01-31
IS2843B (is) 2013-08-15
BRPI0411868A (pt) 2006-08-08
PT1644376E (pt) 2010-09-24
SI1644376T1 (sl) 2010-11-30
US20050032839A1 (en) 2005-02-10
WO2005005427A1 (fr) 2005-01-20
MY139072A (en) 2009-08-28
ES2349780T3 (es) 2011-01-11
AU2004255347B2 (en) 2010-04-08
MA28064A1 (fr) 2006-08-01
GEP20084395B (en) 2008-06-10
EA200600209A1 (ru) 2006-06-30
HN2004000232A (es) 2011-01-17
UA81682C2 (en) 2008-01-25
DOP2004000949A (es) 2005-01-15
JP2009513525A (ja) 2009-04-02
PL1644376T3 (pl) 2011-03-31
GT200400133A (es) 2005-04-18
CA2531759A1 (fr) 2005-01-20
CR8171A (es) 2006-08-09
CN1820009A (zh) 2006-08-16
AP2214A (en) 2011-03-04
BRPI0411868B1 (pt) 2019-11-12
ECSP056246A (es) 2006-04-19
HK1089769A1 (en) 2006-12-08
TW200510385A (en) 2005-03-16
EA009462B1 (ru) 2007-12-28

Similar Documents

Publication Publication Date Title
TNSN06009A1 (fr) Derives de pyrrolo [3,4-c] pyrazole actifs comme inhibiteurs de kinases
TNSN01095A1 (fr) DERIVES DE PYRROLO [2,3-d] PYRIMIDINE NOUVEAUX ET COMPOSITIONS LES CONTENANT
TNSN06244A1 (fr) Derives de 1h-thieno [2,3-c] pyrazole utiles comme inhibiteurs de kinases
TNSN99125A1 (fr) Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN05298A1 (fr) Derives de pyrazolo-quinazoline, procede pour leur preparation et leur utilisation comme inhibiteurs de kinases
MA30952B1 (fr) Cyclopenta [d] pyrimidines utiles en tant qu'inhibiteurs de la proteine kinase akt
MY139355A (en) Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
PL1678166T3 (pl) Inhibitory kinaz białkowych
TNSN05176A1 (fr) Derives de diazepino-indole servant d'inhibiteurs de kinases
TNSN98238A1 (fr) Macrolides nouveaux
WO2002044183A3 (fr) Composes et leurs utilisations
WO2002012242A3 (fr) Bicyclo-pyrazoles actifs en tant qu'inhibiteurs de kinase, leur procede de preparation et compositions pharmaceutiques les contenant
WO2002046170A8 (fr) Derives d'anilinopyrimidine utilises comme inhibiteurs du chemin de la kinase de n terminal (jnk) et compositions et techniques associees
SG132683A1 (en) Imidazopyrazine tyrosine kinase inhibitors
TNSN06186A1 (fr) Pyrido [2,3-d] pyrimidine -2, 4-diamines servant d'inhibiteurs de pde 2
CA2400447A1 (fr) Inhibiteurs de kinases
TN2010000171A1 (fr) Derives de thienopyrimidine et pyrazolopyrimidine et leur utilisation comme inhibiteurs de la kinase mtor te de la kinase k13
MY141220A (en) Pyrazole derivatives as inhibitors of receptor tyrosine kinases
MA27933A1 (fr) Inhibiteurs de l'activite de akt
UA88012C2 (uk) Похідні хіназоліндіону як інгібітори parp
MA29713B1 (fr) Derives de tetrahydroindolone et de tetrahydroindazolone
ZA200500716B (en) Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
WO2008005956A3 (fr) Inhibiteurs de pyrrolotriazine kinase
MA28038A1 (fr) Thienopyrazoles